Primary Systemic Amyloidosis
Information
- Disease name
- Primary Systemic Amyloidosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03499808 | Active, not recruiting | Phase 2 | S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis | June 6, 2018 | July 31, 2025 |
| NCT00014235 | Completed | N/A | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | December 2000 | |
| NCT00025415 | Completed | Phase 1 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | August 2001 | |
| NCT00112593 | Completed | N/A | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer | November 1999 | |
| NCT00224393 | Completed | Phase 2 | Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis | February 2001 | August 31, 2005 |
| NCT00520767 | Completed | Phase 2 | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease | September 2007 | June 6, 2019 |
| NCT00536601 | Completed | N/A | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | June 29, 2006 | July 9, 2018 |
| NCT00890747 | Completed | Phase 1 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | August 2009 | |
| NCT00006251 | Completed | Phase 1/Phase 2 | Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer | May 2000 | |
| NCT01072773 | Completed | Phase 2 | Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis | March 2010 | June 2012 |
| NCT01078454 | Completed | Phase 3 | Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis | November 2010 | November 27, 2012 |
| NCT01194791 | Completed | Phase 2 | Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed | October 2010 | December 2016 |
| NCT01199562 | Completed | Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant | December 2010 | December 2013 | |
| NCT01053494 | Completed | N/A | Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer | April 2010 | February 2012 |
| NCT01849783 | Completed | Phase 2 | Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma | April 4, 2013 | September 30, 2020 |
| NCT02207556 | Completed | Phase 2 | Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial | October 1, 2014 | May 19, 2020 |
| NCT01728259 | Terminated | Phase 1 | First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD | March 2013 | October 31, 2018 |
| NCT00030381 | Terminated | Phase 1 | Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis | December 2001 |
- OrphaNumber from OrphaNet (Orphanet)
- 314701